Evidence map›Paper›PMID 22014658›Full record

ArticleJournal of the American College of Surgeons2011

Age, comorbidity, and breast cancer severity: impact on receipt of definitive local therapy and rate of recurrence among older women with early-stage breast cancer.

Terry S Field, Jaclyn L F Bosco, Marianne N Prout, Heather T Gold, Sarah Cutrona, Pamala A Pawloski, Marianne Ulcickas Yood, Virginia P Quinn, Soe Soe Thwin, Rebecca A Silliman

Abstract read
In one paragraph

Article in Journal of the American College of Surgeons, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed
2.3field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 34 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Observational
  6. Article
  7. Article
  8. Article
  9. Article
  10. Comorbidity burden and guideline-concordant care for breast cancer.Journal of the American Geriatrics Society · 2014
    Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Patient, hospital, and neighborhood factors associated with treatment of early-stage breast cancer among Asian American women in California.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2012
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors at 6 institutions in 1 country.

Terry S FieldMeyers Primary Care Institute, Worcester, MA 01605, USA. Terry.Field@umassmed.edu
Jaclyn L F Bosco
Marianne N Prout
Heather T Gold
Sarah Cutrona
Pamala A Pawloski
Marianne Ulcickas Yood
Virginia P Quinn
Soe Soe Thwin
Rebecca A Silliman
Boston University · USCornell University · USHealthPartners · USKaiser Permanente · USUniversity of Massachusetts Chan Medical School · USVA Boston Healthcare System · US

Funding

Long-term Survivorship in Older Women with Early Stage Breast CancerR01CA093772 · NCI · BOSTON MEDICAL CENTER · PI SILLIMAN, REBECCA A · 2003 to 2011
$7.5M
NCI NIH HHS R01 CA093772
6 · The paper itself

Abstract

backgroundThe definitive local therapy options for early-stage breast cancer are mastectomy and breast-conserving surgery followed by radiation therapy. Older women and those with comorbidities frequently receive breast-conserving surgery alone. The interaction of age and comorbidity with breast cancer severity and their impact on receipt of definitive therapy have not been well-studied. STUDY

designIn a cohort of 1,837 women aged 65 years and older receiving treatment for early-stage breast cancer in 6 integrated health care delivery systems in 1990-1994 and followed for 10 years, we examined predictors of receiving nondefinitive local therapy and assessed the impact on breast cancer recurrence within levels of severity, defined as level of risk for recurrence.

resultsAge and comorbidity were associated with receipt of nondefinitive therapy. Compared with those at low risk, women at the highest risk were less likely to receive nondefinitive therapy (odds ratio = 0.32; 95% CI, 0.22-0.47), and women at moderate risk were about half as likely (odds ratio = 0.54; 95% CI, 0.35-0.84). Nondefinitive local therapy was associated with higher rates of recurrence among women at moderate (hazard ratio = 5.1; 95% CI, 1.9-13.5) and low risk (hazard ratio = 3.2; 95% CI, 1.1-8.9). The association among women at high risk was weak (hazard ratio = 1.3; 95% CI, 0.75-2.1).

conclusionsAmong these older women with early-stage breast cancer, decisions about therapy partially balanced breast cancer severity against age and comorbidity. However, even among women at low risk, omitting definitive local therapy was associated with increased recurrence.

Indexed as

AgedAged, 80 and overAge FactorsBreast NeoplasmsCohort StudiesFemaleHumansMastectomyNeoplasm Recurrence, LocalNeoplasm StagingRadiotherapy, AdjuvantRisk FactorsTreatment Outcome

Identifiers

PMID22014658
PMCPMC3223288
OpenAlexW2075240947

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.